University of Colorado - School of Medicine
The Espinosa Laboratory in the Cancer Division of the Department of Pharmacology at the University of Colorado Denver | Anschutz Medical Campus is seeking independent and creative postdoctoral fellows. The Espinosa Lab utilizes an integrated system of functional genomics and mechanistic studies aimed at making biological discoveries with clear translational potential. Most of our current studies are focused on harnessing the power of pleiotropic transcription factors for cancer treatment Examples of ongoing projects are:
- Elucidation of gene networks governed by transcription factors involved in cancer. We employ functional genomics tools to elucidate the signaling cascades driven by cancer-relevant transcription factors such as p53 and HIF1A across different cell types and stimuli. We aim to elucidate molecular mechanisms that control the cellular response upon activation of these transcription factors, from enhancer priming to metabolic control, with the ultimate goal of harnessing these mechanisms for therapeutic purposes (e.g. Galbraith et al., Cell 2013, Allen et al., eLife 2014, Andrysik et. al., Genome Res 2017).
- Mechanistic studies of transcriptional coactivators and chromatin regulators with oncogenic and tumor suppressive functions. Using a multidimensional approach, from biochemistry to functional genomics, we investigate the role of specific transcriptional coactivators and chromatin factors in cancer development. We are particularly interested in the role of the Mediator Complex in oncogenesis and tumor suppression (e.g. Donner et al., Mol Cell 2007, Donner et al., Nature Struct Mol Biol. 2010, Galbraith et al., Cell 2013, Perez-Perri et al. Cell Reports 2016).
- Pharmacological manipulation of transcription factors and cofactors for therapeutic purposes. Our goal is to identify effective strategies to employ novel biologically targeted therapeutics modulating the activity of transcription factors, cofactors and chromatin regulators for cancer treatment. Presently, we are focused on several first-in-class drugs that modulate transcription factors, Mediator-associated kinases, and epigenetic readers (e.g. Sullivan et al., Nat Chem Biol. 2012, Andrysik et al., Cell Reports 2013).
- Roles of Interferon signaling in Down syndrome and cancer. We are particularly interested in understanding how hyperactivation of Interferon signaling in people with Down syndrome may contribute to the clinical impacts of trisomy 21, including the lower incidence of solid malignancies and higher incidence of leukemias observed in this population (e.g. Sullivan et al., eLIFE 2016; Sullivan et al., Scientific Reports 2017).
Our hope is that these courses of study will lead to clinically actionable discoveries and ultimately improve patient outcomes as well as our understanding of human biology in general. All projects provide ample opportunity for gaining experience with genomic methods to study gene transcription, expression, and epigenetic regulation. We also frequently employ shRNA and CRISPR technology, along with a host of additional advanced molecular, biochemical, and genomic techniques.
• Ph.D. in molecular biology or a related field
• Excellent written and verbal communication skills in English
• Proven ability to work independently within a research lab
• Experience with mammalian tissue culture
Desired or preferred:
Experience with molecular biology methods, such as:
- RT/quantitative PCR
- Western blotting
- RNA interference
- CRISPR / genome editing
- Lenti/retroviral production and transduction
- Flow cytometry 3 years mammalian tissue culture experience Experience with rodent models Experience with generation and analysis of genomic sequence data Experience with standard bioinformatics tools Experience with statistical programming, such as R
Salary and Benefits:
Salary is commensurate with skills and experience. The University of Colorado offers a full benefits package. Information on University benefits programs, including eligibility, is located at Employee Services.
The University of Colorado Denver is dedicated to ensuring a safe and secure environment for our faculty, staff, students and visitors. To assist in achieving that goal, we conduct background investigations for all prospective employees.
The University of Colorado strongly supports the principle of diversity. We encourage applications from women, ethnic minorities, persons with disabilities and all veterans. The University of Colorado is committed to diversity and equality in education and employment.
The Immigration Reform and Control Act requires that verification of employment eligibility be documented for all new employees by the end of the third day of work. Alternative formats of this ad are available upon request for persons with disabilities.
Special Instructions to Applicants:Applicants should apply through CU Careers using job posting number 12717 Review of applications will begin immediately and continue until position is filled.
Application Materials Required:Cover Letter, Resume/CV, List of References
Application Materials Instructions:Required application materials: 1) Cover letter explaining suitability and interest in the position 2) Resume/Curriculum Vitae 3) Proof of doctoral degree (transcript or diploma) 4) Contact information for a minimum of  professional references
Job Category: Faculty
Primary Location: Aurora
Department: H0001 -- Anschutz Medical Campus - 20120 - SOM - Pharmacology
Posting Date: Feb 22, 2018
Closing Date: Ongoing
Posting Contact Name: Jennifer Orsund
Posting Contact Email: [email protected]
Position Number: 00612268